Article
Biallelic mutations in calcium release activated channel regulator 2A (CRACR2A) cause a primary immunodeficiency disorder.
eLife - 15 Dec 2021
Wu Beibei, Rice Laura, Shrimpton Jennifer, Lawless Dylan, Walker Kieran, Carter Clive, McKeown Lynn, Anwar Rashida, Doody Gina M, Srikanth Sonal, Gwack Yousang, Savic Sinisa
Abstract excerpt
CRAC channel regulator 2 A (CRACR2A) is a large Rab GTPase that is expressed abundantly in T cells and acts as a signal transmitter between T cell receptor stimulation and activation of the Ca2+-NFAT and JNK-AP1 pathways. CRACR2A has been linked to human diseases in numerous genome-wide association studies, however, to date no patient with damaging variants in CRACR2A has been identified. In this study, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
